Activities of Branislav ŠKRIPEK related to 2016/2096(INI)
Plenary speeches (2)
Promoting gender equality in mental health and clinical research (A8-0380/2016 - Beatriz Becerra Basterrechea) SK
Promoting gender equality in mental health and clinical research (short presentation)
Amendments (17)
Amendment 25 #
Motion for a resolution
Recital B
Recital B
B. whereas the sex and gender dimensions of health entail that women face a number of specific health risks over their lifetimes;
Amendment 32 #
Motion for a resolution
Recital C
Recital C
C. whereas taking account of women’s diversity and distinctness and incorporating it into the health policies addressed to women would strengthen the effectiveness of these policies;
Amendment 39 #
Motion for a resolution
Recital D
Recital D
D. whereas maternal mortality is regarded as a major marker of health system efficiency, quality and performance;
Amendment 42 #
Motion for a resolution
Recital E
Recital E
Amendment 94 #
Motion for a resolution
Recital M
Recital M
M. whereas, because of a variety of factors, primarily concerning different gendersocial roles and genderexisting inequalities, depression is approximately twice as prevalent among women as it is among men;
Amendment 108 #
Motion for a resolution
Recital O
Recital O
O. whereas male violence against women prevails and its impacts on women’s health constitute a fundamental barrier to the achievement of gender equality and women’s full enjoyment of their human rights;
Amendment 139 #
Motion for a resolution
Paragraph 1 – point b
Paragraph 1 – point b
(b) to recognise male violence against womenany form of violence not only as a social or legal issue but also as a public health issue, whatever form it takes;
Amendment 167 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Recommends that healthcare for pregnant women begin as soon as possible in the first trimester of pregnancy, in order to make it possible to identify specific conditions that may require surveillance, to recognise socialpotential social and health problems for which women may need help from social or mental health services and to inform women about pregnancy-related issues;
Amendment 175 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Encourages the Commission and the Member States to take into account emotional and psychological disorders of women caused by miscarriage and offer them necessary psychological support;
Amendment 180 #
Motion for a resolution
Paragraph 2 b (new)
Paragraph 2 b (new)
2b. Calls on the Commission and the Member States to promote, develop and provide early detection and treatment of postpartum psychosis and postpartum depression;
Amendment 187 #
Motion for a resolution
Paragraph 3
Paragraph 3
Amendment 200 #
Motion for a resolution
Paragraph 4
Paragraph 4
Amendment 208 #
Motion for a resolution
Paragraph 5
Paragraph 5
Amendment 226 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls on the Member States to ensure fullthe necessary access to high-quality care for all migrant women, irrespective of their legal status, and, in the longer term, to adequately prepare their national health systems;
Amendment 259 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
13a. Encourages the Commission and the Member States to pay special attention to the most vulnerable or disadvantaged groups, such as elderly, disabled, socially excluded, Roma, unemployed or addicted women; and launch intervention programs for them;
Amendment 264 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Considers that the lack of comparable, comprehensive, reliable and regularly updated gender-disaggregated data constitutes a source of discrimination for women’s health; calls for the EU institutions and the Member States therefore to promote and make mandatory the collection of comparable gender- disaggregated data at EU and national level;
Amendment 289 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Asks the Commission to incentivise projects at EU level focused on how women are treated in clinical research; such projects should involve and how their rights are protected; such projects should involve various stakeholders, including health authorities at all levels and the pharmaceutical industry;